Susquehanna International Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $838K | Buy |
+23,700
| New | +$964K | ﹤0.01% | 8361 |
|
|
2025
Q4 | – | Sell |
-4,600
| Closed | -$216K | – | 12498 |
|
|
2025
Q3 | $216K | Sell |
4,600
-23,100
| -83% | -$1.2M | ﹤0.01% | 10820 |
|
|
2025
Q2 | $1.44M | Buy |
+27,700
| New | +$1.52M | ﹤0.01% | 6545 |
|
|
2024
Q4 | – | Sell |
-3,500
| Closed | -$252K | – | 12310 |
|
|
2024
Q3 | $252K | Buy |
3,500
+100
| +3% | +$7.06K | ﹤0.01% | 9992 |
|
|
2024
Q2 | $236K | Sell |
3,400
-5,000
| -60% | -$365K | ﹤0.01% | 9994 |
|
|
2024
Q1 | $673K | Buy |
8,400
+2,700
| +47% | +$241K | ﹤0.01% | 7791 |
|
|
2023
Q4 | $624K | Sell |
5,700
-16,200
| -74% | -$1.68M | ﹤0.01% | 8124 |
|
|
2023
Q3 | $2.21M | Sell |
21,900
-9,500
| -30% | -$1.09M | ﹤0.01% | 4925 |
|
|
2023
Q2 | $4.27M | Buy |
31,400
+4,700
| +18% | +$574K | ﹤0.01% | 3775 |
|
|
2023
Q1 | $2.77M | Sell |
26,700
-116,900
| -81% | -$11.3M | ﹤0.01% | 4472 |
|
|
2022
Q4 | $12.7M | Buy |
143,600
+66,500
| +86% | +$5.52M | ﹤0.01% | 1971 |
|
|
2022
Q3 | $6.18M | Buy |
77,100
+74,000
| +2,387% | +$6.98M | ﹤0.01% | 2843 |
|
|
2022
Q2 | $297K | Sell |
3,100
-17,100
| -85% | -$2.05M | ﹤0.01% | 9584 |
|
|
2022
Q1 | $3M | Sell |
20,200
-8,200
| -29% | -$1.15M | ﹤0.01% | 4621 |
|
|
2021
Q4 | $4.03M | Buy |
28,400
+16,200
| +133% | +$2.29M | ﹤0.01% | 4114 |
|
|
2021
Q3 | $1.6M | Sell |
12,200
-22,500
| -65% | -$2.94M | ﹤0.01% | 6326 |
|
|
2021
Q2 | $4.77M | Buy |
34,700
+8,700
| +33% | +$1.19M | ﹤0.01% | 4116 |
|
|
2021
Q1 | $3.4M | Sell |
26,000
-5,000
| -16% | -$602K | ﹤0.01% | 4693 |
|
|
2020
Q4 | $3.47M | Buy |
31,000
+9,900
| +47% | +$937K | ﹤0.01% | 4058 |
|
|
2020
Q3 | $1.66M | Buy |
+21,100
| New | +$1.72M | ﹤0.01% | 4967 |
|
|
2020
Q1 | – | Sell |
-7,200
| Closed | -$805K | – | 10285 |
|
|
2019
Q4 | $805K | Sell |
7,200
-500
| -6% | -$53.3K | ﹤0.01% | 5955 |
|
|
2019
Q3 | $740K | Buy |
+7,700
| New | +$723K | ﹤0.01% | 6381 |
|
|
2019
Q2 | – | Sell |
-16,500
| Closed | -$1.37M | – | 10271 |
|
|
2019
Q1 | $1.37M | Buy |
+16,500
| New | +$1.2M | ﹤0.01% | 4390 |
|
|
2018
Q4 | – | Sell |
-19,400
| Closed | -$1.54M | – | 9034 |
|
|
2018
Q3 | $1.54M | Buy |
+19,400
| New | +$1.5M | ﹤0.01% | 4432 |
|
|
2017
Q2 | – | Sell |
-5,300
| Closed | -$235K | – | 9245 |
|
|
2017
Q1 | $235K | Buy |
+5,300
| New | +$228K | ﹤0.01% | 7769 |
|
|
2016
Q4 | – | Sell |
-9,000
| Closed | -$361K | – | 9611 |
|
|
2016
Q3 | $361K | Buy |
+9,000
| New | +$382K | ﹤0.01% | 6619 |
|
|
2014
Q4 | – | Sell |
-6,000
| Closed | -$221K | – | 9646 |
|
|
2014
Q3 | $221K | Buy |
+6,000
| New | +$238K | ﹤0.01% | 8511 |
|
Other funds holding CNMD
VPM
VCM
CB
Susquehanna International Group's CNMD Position: Q1 2026 in Review
Susquehanna International Group increased its CONMED (CNMD) stake by 200% in Q1 2026, buying an estimated $880K and bringing the position to 32,452 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #7525.
Susquehanna International Group first reported a position in CNMD in Q4 2013 and has held it in 41 quarters since. The position peaked at $2.93M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Susquehanna International Group held 32,452 shares of CONMED worth $1.15M as of Q1 2026.
- Susquehanna International Group bought 21,637 CONMED shares in Q1 2026, an estimated $880K.
- CONMED made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7525 holding.
- Susquehanna International Group first reported a position in CONMED in Q4 2013 and has held it in 41 quarters since.
- Susquehanna International Group's CONMED position peaked at $2.93M in Q4 2021.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.